China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.400
-0.035 (-1.44%)
At close: Sep 18, 2026, 4:00 PM EDT
2.350
-0.050 (-2.08%)
After-hours: Sep 18, 2026, 7:47 PM EDT
China SXT Pharmaceuticals Financials Overview
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Fiscal Quarter | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 0.51 | 0.63 | 0.91 | 0.83 | 0.99 | 0.94 | 0.76 | 1.21 | 1.57 | 1.03 |
Revenue Growth | -43.88% | -24.46% | -7.84% | -11.72% | 29.54% | -22.24% | -51.52% | 17.57% | 71.70% | -73.38% |
Gross Profit Gross Profit Growth | 0.15 | 0.1 | 0.23 | 0.13 | 0.27 | 0.29 | 0.34 | 0.09 | 0.93 | 0.32 |
Operating Income Operating Income Growth | -0.78 | -6.34 | -2.04 | -0.64 | 7.26 | -9.35 | -4.11 | -1.15 | -2.3 | -2.89 |
Net Income Net Income Growth | 0.16 | -6.37 | -2.5 | -0.8 | 6.6 | -9.7 | -4.44 | -1.49 | -2.64 | -3.09 |
Earnings Per Share EPS Growth | - | - | - | - | - | - | - | - | -1.30 | -0.18 |
EPS Growth | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 28.32 | 21.31 | 18.24 | 18.51 | 12.07 | 11.47 | 17.37 | 2.98 | 15.52 | 0.03 |
Total Debt Total Debt Growth | 1.12 | 1.2 | 0.98 | 9.87 | 3.7 | 3.57 | 8.96 | 1.58 | 10.74 | 2.63 |
Net Cash (Debt) Net Cash Growth | 27.2 | 20.1 | 17.25 | 8.64 | 8.38 | 7.89 | 8.41 | 1.41 | 4.78 | -2.6 |
Net Cash Growth | 57.65% | 132.67% | 106.00% | 9.47% | -0.39% | 461.53% | 75.82% | - | 319.07% | - |
Net Cash Per Share Net Cash Per Share Growth | - | - | - | - | - | - | - | - | 2.35 | -0.15 |
| Fiscal Quarter | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -2.26 | -1.75 | -0.99 | -1.36 | -1.35 | -0.58 | 0.47 | -0.55 | 0.58 | -0.31 |
Capital Expenditures CapEx Growth | - | - | -0 | - | -0.01 | - | -0.05 | -0.02 | -0.04 | -0.02 |
Free Cash Flow Free Cash Flow Growth | -2.26 | -1.75 | -0.99 | -1.36 | -1.36 | -0.58 | 0.42 | -0.57 | 0.54 | -0.33 |
Free Cash Flow Growth | - | - | - | - | - | - | -22.53% | - | - | - |
| Fiscal Quarter | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Operating Margin | -153.28% | -1011.69% | -224.07% | -76.95% | 733.81% | -995.02% | -538.08% | -95.21% | -145.95% | -281.37% |
Pretax Margin | 32.01% | -1016.45% | -274.42% | -96.75% | 667.16% | -1031.96% | -581.64% | -123.70% | -167.78% | -269.16% |
Profit Margin | 32.01% | -1016.46% | -274.42% | -96.75% | 667.16% | -1031.96% | -581.64% | -123.70% | -167.93% | -300.86% |
FCF Margin | -442.81% | -279.71% | -108.64% | -163.62% | -137.07% | -61.68% | 54.73% | -47.11% | 34.25% | -32.45% |
| Fiscal Quarter | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
PS Ratio | 1.26 | 118.44 | 19.71 | 1.39 | 0.42 | 0.87 | 1.38 | 0.66 | - | - |